Given the following molecule represented by the SMILES string: Cc1onc(-c2c(Cl)cccc2Cl)c1C(=O)[NH+]1CCc2ccccc2C1, and the following genes: ABCB1,ABL1,ADRA1D,ADRA2B,ADRB2,CA12,CA2,CA9,CACNA1H,CDK2,CHRM1,CHRM3,CHRM4,CNR1,CYP1A2,CYP2C19,CYP2C9,CYP2D6,CYP3A4,DRD2,DRD3,DRD4,EGFR,ESR1,FLT1,HRH1,HTR1A,HTR2A,HTR2B,HTR2C,HTR6,KCNH2,KDR,LCK,MCL1,OPRK1,PPARG,PTGS1,SIGMAR1,SLC6A2,SLC6A4, describe whether the molecule is related to one or a few of these genes in clear, simple and accurate English. Explain the relationship between the molecule and the related genes in detail. You can break down by explain the patterns of the molecule, followed by the gene features. Format the output as 'Step 1:', 'Step 2:', etc., with each step focusing on a specific aspect of the molecule's structure or properties. Finally, summarize the related gene names in a list. Limit the reasoning to at most 5 steps. You can stop after summarizing the related gene names. Step 1: The molecule contains a benzene ring system with substituents such as chlorine atoms and a pyridine ring. These structural features suggest potential interactions with enzymes involved in drug metabolism, particularly those encoded by genes related to cytochrome P450 (CYP) enzymes. Step 2: The presence of a quinoline ring and a pyridine ring, along with a carboxamide group, indicates that this molecule could interact with receptors or transport proteins, which are often associated with G-protein coupled receptors (GPCRs) and neurotransmitter systems. Step 3: Given the presence of a carboxamide group and the overall structure, the molecule might be able to modulate ion channels, which are encoded by genes like KCNH2, suggesting a possible interaction with this gene. Step 4: The molecule’s structure, including the benzene rings and the carboxamide group, could potentially affect genes involved in signal transduction pathways, such as PTGS1, due to its ability to inhibit cyclooxygenase enzymes. Step 5: Considering the diverse structural elements, the molecule might have a broad impact on several genes, but the most likely candidates for direct interaction are those encoding CYP enzymes (CYP1A2, CYP2C19, CYP2C9, CYP2D6, CYP3A4), GPCRs (ADRA1D, ADRA2B, ADRB2, CHRM1, CHRM3, CHRM4, HTR1A, HTR2A, HTR2B, HTR2C, HTR6), and ion channels (CACNA1H, KCNH2). 
Summary of related gene names:
- CYP1A2
- CYP2C19
- CYP2C9
- CYP2D6
- CYP3A4
- ADRA1D
- ADRA2B
- ADRB2
- CHRM1
- CHRM3
- CHRM4
- HTR1A
- HTR2A
- HTR2B
- HTR2C
- HTR6
- KCNH2
- CACNA1H Step 1: The molecule contains a benzene ring system with substituents such as chlorine atoms and a pyridine ring. These structural features suggest potential interactions with enzymes involved in drug metabolism, particularly those encoded by genes related to cytochrome P450 (CYP) enzymes.
Step 2: The presence of a quinoline ring and a pyridine ring, along with a carboxamide group, indicates that this molecule could interact with receptors or transport proteins, which are often associated with G-protein coupled receptors (GPCRs) and neurotransmitter systems.
Step 3: Given the presence of a carboxamide group and the overall structure, the molecule might be able to modulate ion channels, which are encoded by genes like KCNH2, suggesting a possible interaction with this gene.
Step 4: The molecule’s structure, including the benzene rings and the carboxamide group, could potentially affect genes involved in signal transduction pathways, such as PTGS1, due to its ability to inhibit cyclooxygenase enzymes.
Step 5: Considering the diverse structural elements, the molecule might
